SNAI2 and atrial fibrillation: Co-expressed genes significantly differentially expressed between these two groups were then analyzed, ultimately revealing that miR-163 was downregulated in AF patient samples whereas putative miR-163 target genes including SNAI2 and CXCR4 were upregulated in these patients as compared to control individuals.